PATENT CLAIM ANALYSIS

Application Number: 16050602
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "340000"]

Abstract:
The present disclosure relates to compositions and pharmaceutical formulations comprising at least one active pharmaceutical ingredient chosen from nitrocatechol derivatives of formula I as defined herein and salts, esters, hydrates, solvates and derivatives thereof and methods of making said compositions and pharmaceutical formulations.

Claim (Index 56):
A method of treating a central or peripheral nervous system disorder, the method comprising administering a pharmaceutical formulation comprising a composition comprising granules comprising 2,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine 1-oxide to a patient, wherein the composition has a bulk density greater than 0.2 g/mL.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 95.0
- Lexical Diversity: 1.34286
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14825600', '12750956', '12226260', '14014548', '11989447']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8128553619736197
- 35 USC 102 Novelty (BERT): 0.5947154902868266
- Combined Prediction Score: 0.7910413748049404
- Mean Citation Score: 410.17261
- Max Citation Score: 554.2208
- Similarity Product: 447.9440120296479

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test